Yahoo Malaysia Web Search

Sign In

Search results

  1. unitybiotechnology.comUnity Biotechnology • Targeting a Root Cause

    Apr 25, 2024 · Unity Biotechnology is a biotech company that develops senolytic drugs to target senescent cells and treat age-related diseases, such as vision loss and cognitive decline. Learn about their science, pipeline, and latest news on their website.

    • About Us

      WE ASPIRE TO DEVELOP TRANSFORMATIVE MEDICINES TO SLOW, HALT,...

    • The Science

      UNITY is at the forefront of developing a new class of...

    • Pipeline

      UNITY’s goal with UBX1325 is to transformationally improve...

    • Patients

      CLINICAL TRIAL ACCESS Thank you for your interest in UNITY...

    • Investors & Media

      UNITY Biotechnology is developing therapeutics to slow, halt...

    • Work with us

      At UNITY, we foster an inclusive culture that celebrates...

    • Contact Us

      285 East Grand Avenue South San Francisco, CA 94080....

    • Press Releases

      SOUTH SAN FRANCISCO, Calif. , April 15, 2024 (GLOBE...

  2. unitybiotechnology.com › about-usAbout Us • Unity Biotechnology

    Unity Biotechnology is a biotech company that aims to slow, halt, or reverse diseases of aging, such as diabetic macular edema and age-related neurologic conditions. Learn about their management, board, founders, steering team, advisory team, and company culture.

  3. en.wikipedia.org › wiki › Unity_BiotechnologyUnity Biotechnology - Wikipedia

    Unity Biotechnology is a publicly traded American biotechnology company that develops drugs that target senescent cells.

  4. unitybiotechnology.com › the-scienceThe Science • Unity Biotechnology

    Unity Biotechnology is developing senolytic medicines to selectively eliminate or modulate senescent cells, which are a common feature of age-related diseases. The company is currently testing senolytic drugs for eye diseases, neurodegenerative diseases, and longevity.

  5. ir.unitybiotechnology.comInvestors & Media - Unity Biotechnology

    Mar 15, 2022 · Unity Biotechnology is a biotech company developing therapeutics to target cellular senescence and aging-related biology in ophthalmologic and neurologic diseases. Find stock information, news releases, presentations, and in-the-news articles on its website.

  6. ir.unitybiotechnology.com › press-releasesPress Releases | Unity Biotechnology

    Feb 6, 2024 · SOUTH SAN FRANCISCO, Calif. , April 15, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the fourth quarter and full year ended December 31, 2023

  7. ir.unitybiotechnology.com › news-releases › news-releaseUNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study...

    Dec 12, 2023 · UNITY Biotechnology is a biotech company developing senolytic therapies for aging-related diseases. It has dosed the first patients in a Phase 2 trial of UBX1325, a Bcl-xL inhibitor, for diabetic macular edema (DME), a vision-threatening condition.